RIGL·766559702·US·Common Stock·Healthcare - Biotechnology-13D/G
RIGL (RIGEL PHARMACEUTICALS INC) is held by 96 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($47.8M), STATE STREET CORP ($30.3M), MARSHALL WACE, LLP ($16.2M). Net institutional sentiment: Mixed.
Showing 1-20 of 111
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer